The Challenge of Hemorrhagic Shock Management During Low-Molecular-Weight Heparin Treatment

被引：0

作者：

Morotti, Alessandro ^{[1
]}

Branca, Enrica ^{[1
]}

Guerrasio, Angelo ^{[1
]}

机构：

[1] Univ Turin, Dept Clin & Biol Sci, Reg Gonzole 10, I-10043 Orbassano, Italy

来源：

JOURNAL OF BLOOD MEDICINE | 2020年 / 11卷

关键词：

LMWH bleeding; LMWH reversal; FVIIa; protamine; mantle lymphoma; REVERSAL;

D O I：

10.2147/JBM.S232109

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The reversal of low-molecular-weight heparin (LMWH) and the management of bleeding patients on LMWH remain highly challenging. Even if LMWH is very extensively administered in the prophylaxis and treatment of venous thrombosis, specific antidotes are lacking, and reversal strategies have very weak grade of evidences on clinical effectiveness. We here describe a reversal strategy with protamine and FVIIa in a patient presenting with hemorrhagic shock and cardiocirculatory arrest.

引用

页码：103 / 105

页数：3

共 29 条

[21] An investigation of the effects of heparin, low molecular weight heparin, protamine, and fentanyl on the balance of pro- and anti-inflammatory cytokines in in-vitro monocyte cultures
McBride, WT
Armstrong, MA
McMurray, TJ
ANAESTHESIA, 1996, 51 (07) : 634 - 640
[22] Incomplete Reversal of Enoxaparin Toxicity by Protamine: Implications of Renal Insufficiency, Obesity, and Low Molecular Weight Heparin Sulfate Content
Lakhmir S Chawla
Graham Moore
Michael G Seneff
Obesity Surgery, 2004, 14 : 695 - 698
[23] Incomplete reversal of enoxaparin toxicity by protamine: Implications of renal insufficiency, obesity, and low molecular weight heparin sulfate content
Chawla, LS
Moore, G
Seneff, MG
OBESITY SURGERY, 2004, 14 (05) : 695 - 698
[24] A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents
Charles E. Mahan
Journal of Thrombosis and Thrombolysis, 2014, 37 : 271 - 278
[25] The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance
Wan, Chung Ping Leon
Letchford, Kevin
Jackson, John K.
Burt, Helen M.
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 : 379 - 391
[26] Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy
Loughlin, Gerard
Datino Romaniega, Tomas
Garcia-Fernandez, Javier
Calvo, David
Salgado, Ricardo
Alonso, Andres
Li, Xin
Arenal, Angel
Gonzalez-Torrecilla, Esteban
Atienza, Felipe
Fernandez-Aviles, Francisco
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2016, 45 (02) : 149 - 158
[27] Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy
Gerard Loughlin
Tomás Datino Romaniega
Javier Garcia-Fernandez
David Calvo
Ricardo Salgado
Andres Alonso
Xin Li
Angel Arenal
Esteban González-Torrecilla
Felipe Atienza
Francisco Fernández-Avilés
Journal of Interventional Cardiac Electrophysiology, 2016, 45 : 149 - 158
[28] Immobilized thermolysin for highly efficient production of low-molecular-weight protamine-An attractive cell-penetrating peptide for macromolecular drug delivery applications
David, Allan E.
Gong, Junbo
Chertok, Beata
Domszy, Roman C.
Moon, Cheol
Park, Yoon Shin
Wang, Nam Sun
Yang, Arthur J.
Yang, Victor C.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2012, 100A (01) : 211 - 219
[29] The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man.
Holst, J
Lindblad, B
Bergqvist, D
Hedner, U
Nordfang, O
Ostergaard, P
THROMBOSIS RESEARCH, 1997, 86 (04) : 343 - 348

← 1 2 3 →